Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Serum testosterone levels, testis volume, and the risk of prostate cancer: are these factors related?

Haliloğlu AH, Gökçe İ, Özcan C, Baltacı S, Yaman Ö.

Turk J Urol. 2013 Mar;39(1):12-5. doi: 10.5152/tud.2012.003.

2.

Ethnical disparities of prostate cancer predisposition: genetic polymorphisms in androgen-related genes.

Li J, Mercer E, Gou X, Lu YJ.

Am J Cancer Res. 2013 Apr 3;3(2):127-51. Print 2013.

3.

A perspective on the role of estrogen in hormone-induced prostate carcinogenesis.

Bosland MC.

Cancer Lett. 2013 Jun 28;334(1):28-33. doi: 10.1016/j.canlet.2012.08.027. Epub 2012 Aug 29. Review.

4.

Hormones and prostate carcinogenesis: Androgens and estrogens.

Bosland MC, Mahmoud AM.

J Carcinog. 2011;10:33. doi: 10.4103/1477-3163.90678. Epub 2011 Dec 8.

5.

Polymorphisms in steroidogenesis genes, sex steroid levels, and high myopia in the Taiwanese population.

Chen ZT, Wang IJ, Liao YT, Shih YF, Lin LL.

Mol Vis. 2011;17:2297-310. Epub 2011 Aug 25.

6.

Fine mapping of a region of chromosome 11q13 reveals multiple independent loci associated with risk of prostate cancer.

Chung CC, Ciampa J, Yeager M, Jacobs KB, Berndt SI, Hayes RB, Gonzalez-Bosquet J, Kraft P, Wacholder S, Orr N, Yu K, Hutchinson A, Boland J, Chen Q, Feigelson HS, Thun MJ, Diver WR, Albanes D, Virtamo J, Weinstein S, Schumacher FR, Cancel-Tassin G, Cussenot O, Valeri A, Andriole GL, Crawford ED, Haiman CA, Henderson BE, Kolonel L, Le Marchand L, Siddiq A, Riboli E, Key TJ, Kaaks R, Isaacs WB, Isaacs SD, Grönberg H, Wiklund F, Xu J, Vatten LJ, Hveem K, Njolstad I, Gerhard DS, Tucker M, Hoover RN, Fraumeni JF Jr, Hunter DJ, Thomas G, Chatterjee N, Chanock SJ.

Hum Mol Genet. 2011 Jul 15;20(14):2869-78. doi: 10.1093/hmg/ddr189. Epub 2011 Apr 29.

7.

A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among Caucasians.

Schumacher FR, Cheng I, Freedman ML, Mucci L, Allen NE, Pollak MN, Hayes RB, Stram DO, Canzian F, Henderson BE, Hunter DJ, Virtamo J, Manjer J, Gaziano JM, Kolonel LN, Tjønneland A, Albanes D, Calle EE, Giovannucci E, Crawford ED, Haiman CA, Kraft P, Willett WC, Thun MJ, Le Marchand L, Kaaks R, Feigelson HS, Bueno-de-Mesquita HB, Palli D, Riboli E, Lund E, Amiano P, Andriole G, Dunning AM, Trichopoulos D, Stampfer MJ, Key TJ, Ma J.

Hum Mol Genet. 2010 Aug 1;19(15):3089-101. doi: 10.1093/hmg/ddq210. Epub 2010 May 19.

8.

PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3).

Dossus L, Kaaks R, Canzian F, Albanes D, Berndt SI, Boeing H, Buring J, Chanock SJ, Clavel-Chapelon F, Feigelson HS, Gaziano JM, Giovannucci E, Gonzalez C, Haiman CA, Hallmans G, Hankinson SE, Hayes RB, Henderson BE, Hoover RN, Hunter DJ, Khaw KT, Kolonel LN, Kraft P, Ma J, Le Marchand L, Lund E, Peeters PH, Stampfer M, Stram DO, Thomas G, Thun MJ, Tjonneland A, Trichopoulos D, Tumino R, Riboli E, Virtamo J, Weinstein SJ, Yeager M, Ziegler RG, Cox DG.

Carcinogenesis. 2010 Mar;31(3):455-61. doi: 10.1093/carcin/bgp307. Epub 2009 Dec 4.

9.

Quantitative trait loci predicting circulating sex steroid hormones in men from the NCI-Breast and Prostate Cancer Cohort Consortium (BPC3).

Ahn J, Schumacher FR, Berndt SI, Pfeiffer R, Albanes D, Andriole GL, Ardanaz E, Boeing H, Bueno-de-Mesquita B, Chanock SJ, Clavel-Chapelon F, Diver WR, Feigelson HS, Gaziano JM, Giovannucci E, Haiman CA, Henderson BE, Hoover RN, Kolonel LN, Kraft P, Ma J, Le Marchand L, Overvad K, Palli D, Stattin P, Stampfer M, Stram DO, Thomas G, Thun MJ, Travis RC, Trichopoulos D, Virtamo J, Weinstein SJ, Yeager M, Kaaks R, Hunter DJ, Hayes RB.

Hum Mol Genet. 2009 Oct 1;18(19):3749-57. doi: 10.1093/hmg/ddp302. Epub 2009 Jul 2.

10.

Polymorphisms in estrogen- and androgen-metabolizing genes and the risk of gastric cancer.

Freedman ND, Ahn J, Hou L, Lissowska J, Zatonski W, Yeager M, Chanock SJ, Chow WH, Abnet CC.

Carcinogenesis. 2009 Jan;30(1):71-7. doi: 10.1093/carcin/bgn258. Epub 2008 Nov 17.

11.

HSD17B1 genetic variants and hormone receptor-defined breast cancer.

Gaudet MM, Chanock S, Dunning A, Driver K, Brinton LA, Lissowska J, Peplonska B, Pharoah P, Garcia-Closas M.

Cancer Epidemiol Biomarkers Prev. 2008 Oct;17(10):2766-72. doi: 10.1158/1055-9965.EPI-07-2891.

12.

Increased prevalence of EGFR-mutant lung cancer in women and in East Asian populations: analysis of estrogen-related polymorphisms.

Bell DW, Brannigan BW, Matsuo K, Finkelstein DM, Sordella R, Settleman J, Mitsudomi T, Haber DA.

Clin Cancer Res. 2008 Jul 1;14(13):4079-84. doi: 10.1158/1078-0432.CCR-07-5030.

13.

A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study.

Murabito JM, Rosenberg CL, Finger D, Kreger BE, Levy D, Splansky GL, Antman K, Hwang SJ.

BMC Med Genet. 2007 Sep 19;8 Suppl 1:S6.

14.

Imputation-based analysis of association studies: candidate regions and quantitative traits.

Servin B, Stephens M.

PLoS Genet. 2007 Jul;3(7):e114. Epub 2007 May 30.

Items per page

Supplemental Content

Write to the Help Desk